News – Page 970 – Endpoints News

The world's top 10 blockbusters — and what they tell us about R&D trends

7 years ago

South Korean investigators raid stock exchange in another Samsung BioLogics IPO probe — report

7 years ago

Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid ...

7 years ago

Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a ...

7 years ago

Surrozen banks $50M round to fuel its drive to the clinic with regenerative med platform

7 years ago

Biotech C4 raids NIBR for new CMO; EU regulators greenlight Hemlibra expanded label

7 years ago

Bristol-Myers dodges a bullet as PTAB turns down inter partes review pitch for Celgene's cash cow

7 years ago

Merck notches fourth lung cancer approval in Europe for flagship Keytruda

7 years ago

J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs

7 years ago

Deerfield takes translational partnership model to Harvard with $100M deal

7 years ago

CEO of biotech investor Hercules Capital abandons his post in the midst of a college cheating scandal

7 years ago

Scandal-prone Subsys maker Insys falls as auditor flags going concern doubt

7 years ago

Novartis' Sandoz chief is walking out in the middle of a global revamp, fueling fresh buzz about a spinoff

7 years ago

Cambridge's TriNetX raises $40M for clinical analytics platform; NovaBay chops its sales force, appoints new chief

7 years ago

Celgene's chemotherapy Abraxane stumbles in pivotal pancreatic cancer study

7 years ago

Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big ...

7 years ago

Endpoints News poll: Industry insiders offer a big 👍 for Ned Sharpless

7 years ago

One of the top late-stage drugs Bristol-Myers wants in its $74B Celgene deal faces a ‘roadblock’ — analyst

7 years ago

US lawmakers now want to hear from the middlemen PBMs to unpack their role in drug pricing

7 years ago

Less than a year after Rhopressa launch, Aerie scores new glaucoma drug approval

7 years ago

FDA unveils 5 guidances on broadening cancer clinical trial eligibility

7 years ago

Bristol-Myers CEO Caforio wants M&A dissidents to know there's been no 'high level' overtures about buying the ...

7 years ago

Markets buzz as another mRNA biotech unicorn looks to carry home a record $800M IPO haul

7 years ago

NCI's Ned Sharpless gets the nod to run the FDA in wake of Scott Gottlieb’s surprise exit

7 years ago

First page Previous page 967 968 969970971 972 973 Next page Last page